HIMSS19: CMS innovation center could jumpstart interoperability models

Dive Temporary: CMS might transfer to push early adoption of infrastructure​ selling transparency and stymieing knowledge blocking, Adam Boehler, the top of the company’s cost mannequin testing and innovation heart, hinted Wednesday. Talking at HIMSS19, the top of the Heart for Medicare and Medicaid Innovation stated the middle’s fashions may …

Read More »

Are drugmaker marketing practices to physicians false claims? Gilead Sciences is the latest to come under fire.

The drugmaker Gilead Sciences has been hit with a whistle-blower suit accusing it of paying healthcare suppliers to spice up gross sales of its hepatitis and HIV medicine. In an unsealed False Claims Act case in California federal court docket, a whistle-blower claimed Gilead’s Frontlines of Communities in america program, …

Read More »